Who makes Paracetamole?

Paracetamole is developed by Pamukkale University.

What development phase is Paracetamole in?

Paracetamole is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Paracetamole

Pamukkale University · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Paracetamole
Also known as	Perfalgan
Sponsor	Pamukkale University
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Outcomes of Enhanced Recovery After Cesarean (ERAC) Protocol (NA)
IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Paracetamole CI brief — competitive landscape report
Paracetamole updates RSS · CI watch RSS
Pamukkale University portfolio CI